Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma
This study is currently recruiting participants.
Verified December 2012 by AB Science
Study NCT01470131   Information provided by AB Science

First Received on October 25, 2011.   Last Updated on December 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial